These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 22057873)
1. Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases. Szelenyi I Inflamm Res; 2012 Jan; 61(1):1-9. PubMed ID: 22057873 [TBL] [Abstract][Full Text] [Related]
2. Application of nanotechnology in drug delivery systems for respiratory diseases (Review). Luo MX; Hua S; Shang QY Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125 [TBL] [Abstract][Full Text] [Related]
3. Voyage of theranostic liposomes for imaging and therapy. Sachin M; Sachin D; Dinesh S J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticle therapeutics: a personal perspective. McNeil SE Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):264-71. PubMed ID: 20049796 [TBL] [Abstract][Full Text] [Related]
5. Unique benefits of nanotechnology to drug delivery and diagnostics. McNeil SE Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949 [TBL] [Abstract][Full Text] [Related]
6. Characterization of nanoparticles for therapeutics. Hall JB; Dobrovolskaia MA; Patri AK; McNeil SE Nanomedicine (Lond); 2007 Dec; 2(6):789-803. PubMed ID: 18095846 [TBL] [Abstract][Full Text] [Related]
12. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine. Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373 [TBL] [Abstract][Full Text] [Related]
13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
14. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers. Moritz M; Geszke-Moritz M Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624 [TBL] [Abstract][Full Text] [Related]
15. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications. Al-Jamal WT; Kostarelos K Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195 [TBL] [Abstract][Full Text] [Related]
16. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery. Koning GA; Krijger GC Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918 [TBL] [Abstract][Full Text] [Related]
17. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
18. Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances. Liu Y; Lou C; Yang H; Shi M; Miyoshi H Curr Cancer Drug Targets; 2011 Feb; 11(2):156-63. PubMed ID: 21158720 [TBL] [Abstract][Full Text] [Related]
19. [Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry]. Szebeni J Neuropsychopharmacol Hung; 2011 Mar; 13(1):15-24. PubMed ID: 21451188 [TBL] [Abstract][Full Text] [Related]
20. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine. Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]